NOV 21, 2018 2:29 PM PST

Drug Could Seek New Approach For Autoimmunity

WRITTEN BY: Nouran Amin

From a failed pain drug, a protein called ‘BH4’, was recently discovered to have surprising implications in the treatment of autoimmunity and cancer. It was specifically found that BH4 functions as a kind of “immunological thermostat” capable of raising and lowering the activity levels of an important kind of immune cell population—the T cells.

In colitis, an infiltration of activated T cells (shown in red on the left) is clearly visible in the colon. By blocking the BH4 pathway (shown at right), the researchers were able to deeply suppress T cell function. – Medical Xpress

Credit: Woolf Lab/Boston Childrens Hospital/IMBA

"By targeting BH4, we are able to suppress T cell activity in inflammatory conditions and increase their activity in the case of cancer," says co-leader of the study and Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, PhD. "The ability to target the same pathway in opposite directions is significant and represents a whole new therapeutic approach."

Researchers were able to inhibit T cell proliferation by pharmacologically blocking the BH4 pathway and in cancer models-- T cell responses were enhanced by elevating BH4 levels. Since researchers were aware that T cells need high levels of mitochondrial energy to be activated, and the mitochondria needs high levels of iron to produce that energy—they discovered that BH4 regulated the iron availability. So when the levels of BH4 are significantly low, mitochondria cannot receive iron and T cell activity is thus suppressed.

A simplified version of the BH4 pathway involving three important enzymatic reactions.

Credit: MyGeneFood.com

"The beauty of it is that the effect is upstream of specific types of T cell function," says Woolf. "Most drugs being developed now to treat autoimmune conditions are targeting specific kinds of T cells. This covers them all."

Although not required for the normal production of T cells, the BH4 pathway was found to be active in cases of infection or when proliferation is needed.

Learn more about the development of T Cells:

Researchers were then motivated to create a highly potent small molecule called ‘QM385’ which was found to inhibit the BH4 pathway—ultimately blocking T cell proliferation and autoimmunity.

Findings of the study were published in Nature.

Source: Science Daily, Nature

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 26, 2022
Immunology
Unraveling the Mystery of an Immune Cell Checkpoint
APR 26, 2022
Unraveling the Mystery of an Immune Cell Checkpoint
The immune system can get tired when it has to fight against a chronic infection or a disease like cancer. Exhausted T c ...
APR 28, 2022
Genetics & Genomics
A Genetic Cause of Lupus is Identified
APR 28, 2022
A Genetic Cause of Lupus is Identified
Lupus is an autoimmune disease that can impact anyone, but tends to affects women between the ages of 15 and 45. The dis ...
MAY 26, 2022
Drug Discovery & Development
Sonic Hedgehog gene speeds up large-scale bone regeneration
MAY 26, 2022
Sonic Hedgehog gene speeds up large-scale bone regeneration
Some species of lizards can detach their tails from their bodies when they feel threatened. This common defense mechanis ...
JUN 17, 2022
Cannabis Sciences
Projected Increases in Cannabis Use in States Legalizing Recreational Cannabis
JUN 17, 2022
Projected Increases in Cannabis Use in States Legalizing Recreational Cannabis
A study published in the scientific journal Addiction found that people will be more likely to use cannabis as their sta ...
JUN 27, 2022
Plants & Animals
Developing a New Approach to Rabies Vaccination
JUN 27, 2022
Developing a New Approach to Rabies Vaccination
Rabies is a viral disease that can spread through the saliva. Several kinds of animals can get rabies, including humans ...
JUN 29, 2022
Microbiology
Unleashing the Genetic Power of Ocean Microbes
JUN 29, 2022
Unleashing the Genetic Power of Ocean Microbes
By analyzing over 1,000 samples of the marine environment, researchers have reconstructed the genomes of 25,000 novel mi ...
Loading Comments...